Selected research
Market Outlook & Growth Opportunities
Global Veterinary Health Products Market Outlook and Growth Opportunities 2026
Market perspective
The global Veterinary Health Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Veterinary Health Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Veterinary Health Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Veterinary Health Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Veterinary Health Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Veterinary Health Products market include Zoetis, Novartis Animal Health, Bayer, BASF, Virbac, Heska, Elanco, DSM and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Veterinary Health Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Veterinary Health Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Veterinary Health Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary Health Products market.
Veterinary Health Products Segment by Company
Zoetis
Novartis Animal Health
Bayer
BASF
Virbac
Heska
Elanco
DSM
Boehringer Ingelheim
Alpharma Animal Health
Adisseo France
Veterinary Health Products Segment by Type
Vaccines
Performance Enhancers
Feed Additives
Animal Pharmaceuticals
Others
Veterinary Health Products Segment by Application
Poultry
Livestock
Pet
Veterinary Health Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Veterinary Health Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Veterinary Health Products key companies, revenue, market share, and recent developments.
3. To split the Veterinary Health Products breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Veterinary Health Products market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Veterinary Health Products significant trends, drivers, influence factors in global and regions.
6. To analyze Veterinary Health Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Health Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Health Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Health Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Health Products industry.
Chapter 3: Detailed analysis of Veterinary Health Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Veterinary Health Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Veterinary Health Products in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccines
- Performance Enhancers
- Feed Additives
- Animal Pharmaceuticals
- Others
Applications
- Poultry
- Livestock
- Pet
Companies covered
- Zoetis
- Novartis Animal Health
- Bayer
- BASF
- Virbac
- Heska
- Elanco
- DSM
- Boehringer Ingelheim
- Alpharma Animal Health
- Adisseo France
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Veterinary Health Products Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Veterinary Health Products Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Veterinary Health Products Market Dynamics
- 2.1 Veterinary Health Products Industry Trends
- 2.2 Veterinary Health Products Industry Drivers
- 2.3 Veterinary Health Products Industry Opportunities and Challenges
- 2.4 Veterinary Health Products Industry Restraints
3 Veterinary Health Products Market by Company
- 3.1 Global Veterinary Health Products Company Revenue Ranking in 2025
- 3.2 Global Veterinary Health Products Revenue by Company (2021-2026)
- 3.3 Global Veterinary Health Products Company Ranking (2024-2026)
- 3.4 Global Veterinary Health Products Company Manufacturing Base and Headquarters
- 3.5 Global Veterinary Health Products Company Product Type and Application
- 3.6 Global Veterinary Health Products Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Veterinary Health Products Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Veterinary Health Products Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Veterinary Health Products Market by Type
- 4.1 Veterinary Health Products Type Introduction
- 4.1.1 Vaccines
- 4.1.2 Performance Enhancers
- 4.1.3 Feed Additives
- 4.1.4 Animal Pharmaceuticals
- 4.1.5 Others
- 4.2 Global Veterinary Health Products Sales Value by Type
- 4.2.1 Global Veterinary Health Products Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Veterinary Health Products Sales Value by Type (2021-2032)
- 4.2.3 Global Veterinary Health Products Sales Value Share by Type (2021-2032)
5 Veterinary Health Products Market by Application
- 5.1 Veterinary Health Products Application Introduction
- 5.1.1 Poultry
- 5.1.2 Livestock
- 5.1.3 Pet
- 5.2 Global Veterinary Health Products Sales Value by Application
- 5.2.1 Global Veterinary Health Products Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Veterinary Health Products Sales Value by Application (2021-2032)
- 5.2.3 Global Veterinary Health Products Sales Value Share by Application (2021-2032)
6 Veterinary Health Products Regional Value Analysis
- 6.1 Global Veterinary Health Products Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Veterinary Health Products Sales Value by Region (2021-2032)
- 6.2.1 Global Veterinary Health Products Sales Value by Region: 2021-2026
- 6.2.2 Global Veterinary Health Products Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Veterinary Health Products Sales Value (2021-2032)
- 6.3.2 North America Veterinary Health Products Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Veterinary Health Products Sales Value (2021-2032)
- 6.4.2 Europe Veterinary Health Products Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Veterinary Health Products Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Veterinary Health Products Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Veterinary Health Products Sales Value (2021-2032)
- 6.6.2 South America Veterinary Health Products Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Veterinary Health Products Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Veterinary Health Products Sales Value Share by Country, 2025 VS 2032
7 Veterinary Health Products Country-level Value Analysis
- 7.1 Global Veterinary Health Products Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Veterinary Health Products Sales Value by Country (2021-2032)
- 7.2.1 Global Veterinary Health Products Sales Value by Country (2021-2026)
- 7.2.2 Global Veterinary Health Products Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.7.2 France Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.14.2 China Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.17.2 India Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Veterinary Health Products Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Veterinary Health Products Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Veterinary Health Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Zoetis
- 8.1.1 Zoetis Company Information
- 8.1.2 Zoetis Business Overview
- 8.1.3 Zoetis Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.1.4 Zoetis Veterinary Health Products Product Portfolio
- 8.1.5 Zoetis Recent Developments
- 8.2 Novartis Animal Health
- 8.2.1 Novartis Animal Health Company Information
- 8.2.2 Novartis Animal Health Business Overview
- 8.2.3 Novartis Animal Health Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis Animal Health Veterinary Health Products Product Portfolio
- 8.2.5 Novartis Animal Health Recent Developments
- 8.3 Bayer
- 8.3.1 Bayer Company Information
- 8.3.2 Bayer Business Overview
- 8.3.3 Bayer Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.3.4 Bayer Veterinary Health Products Product Portfolio
- 8.3.5 Bayer Recent Developments
- 8.4 BASF
- 8.4.1 BASF Company Information
- 8.4.2 BASF Business Overview
- 8.4.3 BASF Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.4.4 BASF Veterinary Health Products Product Portfolio
- 8.4.5 BASF Recent Developments
- 8.5 Virbac
- 8.5.1 Virbac Company Information
- 8.5.2 Virbac Business Overview
- 8.5.3 Virbac Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.5.4 Virbac Veterinary Health Products Product Portfolio
- 8.5.5 Virbac Recent Developments
- 8.6 Heska
- 8.6.1 Heska Company Information
- 8.6.2 Heska Business Overview
- 8.6.3 Heska Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.6.4 Heska Veterinary Health Products Product Portfolio
- 8.6.5 Heska Recent Developments
- 8.7 Elanco
- 8.7.1 Elanco Company Information
- 8.7.2 Elanco Business Overview
- 8.7.3 Elanco Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.7.4 Elanco Veterinary Health Products Product Portfolio
- 8.7.5 Elanco Recent Developments
- 8.8 DSM
- 8.8.1 DSM Company Information
- 8.8.2 DSM Business Overview
- 8.8.3 DSM Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.8.4 DSM Veterinary Health Products Product Portfolio
- 8.8.5 DSM Recent Developments
- 8.9 Boehringer Ingelheim
- 8.9.1 Boehringer Ingelheim Company Information
- 8.9.2 Boehringer Ingelheim Business Overview
- 8.9.3 Boehringer Ingelheim Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.9.4 Boehringer Ingelheim Veterinary Health Products Product Portfolio
- 8.9.5 Boehringer Ingelheim Recent Developments
- 8.10 Alpharma Animal Health
- 8.10.1 Alpharma Animal Health Company Information
- 8.10.2 Alpharma Animal Health Business Overview
- 8.10.3 Alpharma Animal Health Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.10.4 Alpharma Animal Health Veterinary Health Products Product Portfolio
- 8.10.5 Alpharma Animal Health Recent Developments
- 8.11 Adisseo France
- 8.11.1 Adisseo France Company Information
- 8.11.2 Adisseo France Business Overview
- 8.11.3 Adisseo France Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 8.11.4 Adisseo France Veterinary Health Products Product Portfolio
- 8.11.5 Adisseo France Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst